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ABSTRACT
Increased production of neurotoxic forms of amyloid β (Aβ) peptide via altered
proteolytic cleavage from its precursor, the amyloid protein precursor (APP), and abnormalities
in neuronal calcium homeostasis play central roles in the pathogenesis of Alzheimer’s disease
(AD). Notch1, a membrane receptor that controls cell fate decisions during development of the
nervous system, has been linked to AD because it is a substrate for the γ-secretase enzyme
activity that involves the presenilin-1 protein in which mutations cause early-onset inherited AD.
Numb is an evolutionarily conserved endocytic adapter involved in the internalization of
transmembrane receptors. Mammals produce four Numb isoforms that differ in two functional
domains, a phosphotyrosine-binding domain (PTB) and a proline-rich region (PRR). Expression
of these alternative spliced Numb transcripts is tightly regulated both temporally and spatially
during development and aberrant Numb isoform expression has been associated with increased
risk for cancers. Recent studies showed that the PTB domain of Numb interacts with the
cytoplasmic tails of APP and Notch but the functional relevance of these interactions with
respect to AD pathogenesis is not clear. In the current study, we proposed to investigate the
biological consequences of the interaction of the Numb proteins with APP and Notch in neural
cells stably overexpressing each of the four human Numb proteins.
Converging lines of evidence indicate that the endocytic pathway is involved in the
aberrant processing of APP. Yet little is known about the underlying regulatory mechanism of
APP endocytosis and trafficking. Elucidating the functional consequences of the interaction of
APP with the Numb endocytic adapter proteins will provide a better understanding of the
underlying mechanisms of aberrant APP processing. In the first part of our studies, we found that
expression of the Numb isoforms lacking the insert in the PTB (SPTB-Numb) caused the
iii

abnormal accumulation of cellular APP in the early endosomes, and increased the levels of Cterminal APP fragments and Aβ. By contrast, expression of the Numb isoforms with the insert in
PTB (LPTB-Numb) leads to the depletion of cellular APP and coincides with significantly lower
production of APP derivatives and Aβ. The contrasting effects of the Numb isoforms on APP
metabolism appeared to be independent of the composition of the PRR domain and were not
attributed to differences in the expression of APP nor the activities of the various APPprocessing secretases.
Evidence is emerging that Notch signaling plays a role in the regulation of apoptosis in
neural progenitors and in post-mitotic neurons. Numb has been shown to suppress Notch
signaling by enhancing endocytosis and degradation of the Notch receptor. Whether the aberrant
expression of the Numb isoforms leads to aberrant Notch signaling, and how this might promote
neuronal degeneration is still not known. In the second part of our studies, we found that
expression of SPTB-Numb protein enhances neuronal vulnerability to serum deprivation-induced
cell death by a mechanism involving the dysregulation of cellular calcium homeostasis. Neural
cells expressing SPTB-Numb exhibited markedly higher protein levels of transient receptor
potential canonical 6 (TRPC6) channels and increased calcium entry in response to store
depletion. These effects are mediated by Notch1 as pharmacological inhibition of Notch1
abrogated TRPC6 upregulation. We also found that serum deprivation increased TRPC6
upregulation by a mechanism dependent on Notch activation. Knockdown of TRPC6 expression
stabilized intracellular calcium homeostasis and significantly suppressed serum deprivationinduced death suggesting that Notch-dependent TRPC6 upregulation contributes in part to
serum-deprivation induced death. Interestingly, expression of LPTB-Numb protein suppressed
serum deprivation-induced activation of Notch and the subsequent upregulation of TRPC6 and
iv

cell death. The latter finding further strengthens the link between the Numb isoform specific
effect on Notch activation and the Notch-dependent upregulation of TRPC6. Finally, we showed
that the Numb proteins differentially impact Notch activation by altering the endocytic
trafficking and processing of Notch. Taken together, these studies demonstrate that aberrant
expression of the Numb proteins may influence APP metabolism and Notch-mediated cellular
responses to injury by altering their endocytic trafficking and processing.
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Sisyphus
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CHAPTER I
NUMB ENDOCYTIC ADAPTER PROTEINS REGULATE THE
TRANSPORT AND PROCESSING OF THE AMYLOID PRECURSOR
PROTEIN IN AN ISOFORM-DEPENDENT MANNER: IMPLICATIONS
FOR ALZHEIMER’S DISEASE PATHOGENESIS
Introduction
The amyloid precursor protein (APP) is an integral transmembrane glycoprotein which is highly
expressed in the brain and plays an important role in neuronal function 1. The abnormal
processing of APP to generate the amyloid β-peptide (Aβ) leads to the extracellular neuritic
plaques characteristic of Alzheimer’s disease (AD)

1-3

(Fig. 1). The rate of Aβ production is

believed to be a key determinant of the onset and progression of AD. While proteolytic
processing of APP and characterization of the APP-cleaving enzymes (α-, β- and γ-secretases)
have revealed important targets for drug discovery, the regulation of APP trafficking is less well
understood.

ALZHEIMER’S DISEASE
SENILE PLAQUES

Figure 1. APP processing and amyloid β peptide (Aβ) deposition
1

Several recent findings support the idea that the intracellular transport and subcellular
localization of APP are crucial determinants of APP processing and Aβ generation.

4, 5

. One

pathway for Aβ generation involves the re-internalization of membrane-bound full length APP 4,
5

. Endosomes have been shown to be intracellular compartments where the sequential action of

β-and γ-secretases generates amyloidogenic C-terminal fragments of APP (APP-CTFs) and Aβ 13

. APP is also targeted to, and degraded in, the lysosomes 6. On the other hand, cleavage within

the Aβ region of APP by α-secretase, which prevents the production of Aβ, occurs in a late
compartment of the secretory pathway such as the Golgi or at the cell surface 7 (Fig. 2). Deletion
of the APP cytoplasmic tail or inhibition of endocytosis has been shown to reduce Aβ levels
suggesting that endocytosis is critical for Aβ generation

4, 5, 8

. Understanding the mechanisms

that regulate APP trafficking to distinct subcellular compartments with the different secretase
activities is important for developing strategies to reduce abnormal processing and to prevent
Aβ-induced neurotoxicity.
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Figure 2. Sub-cellular localization of APP processing
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Numb is an evolutionarily conserved protein identified by its ability to control cell fate
in the nervous system of Drosophila

9, 10

. Numb contains two protein-protein interaction

domains, a phosphotyrosine-binding (PTB) domain and a proline-rich region (PRR) that
functions as an SH3-binding domain 11, 12. Whereas only one form of Numb has been identified
in Drosophila, mammals produce four alternatively spliced variants of Numb that differ in the
length of their PTB (lacking or containing an 11 amino acid insert) and PRR (lacking or
containing a 48 amino acid insert) domains

11, 12

. All Numb proteins contain the NPF

(asparagine-proline-phenylalanine) and DPF (aspartate-proline-phenylalanine) motifs that are
critical for interaction with proteins containing the Eps15 Homology (EH) domain and with the
clathrin protein AP-2, respectively (Fig. 3). Numb can associate with clathrin-coated pits,
vesicles and endosomes, suggesting it functions as an endocytic adapter protein

13, 14

. Numb

plays a role in the internalization of receptors that are not only involved in cell-fate decisions
during CNS development

15

, but also in neuronal maturation, differentiation and survival

16, 17

.

Notch is an evolutionary conserved transmembrane receptor that specifies cell fate in a wide
variety of tissues and organisms through local cell-cell interaction
endocytic and ubiquitin-dependent processing of Notch
decisions determined by Notch signaling

20, 21

19

18

. Numb regulates the

and consequently the cell fate

. In maturing neurons, Numb binds to the neural

adhesion protein L1 and integrin in axonal growth cones and promotes their recycling 22, 23.
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Figure 3. Numb isoforms and their structural domains
Previous work has demonstrated an interaction between APP and Numb in mouse brain
lysates and in cell culture

24

. Truncation and site-directed mutagenesis studies have shown that

Numb binds to the YENPTY motif within the intracellular domain of APP 24. Several other APP
binding partners that interact with this motif including X11, Fe65, mDab, C-Abl and JIP-1 have
been demonstrated to affect endogenous APP localization and processing

25

. Considering that

Numb is an endocytic adapter protein, we determined whether expression of Numb influences
the trafficking and processing of APP. Our results show that expression of Numb isoforms
lacking the insert in the PTB (short PTB- or SPTB-Numb) caused the abnormal accumulation of
cellular APP in the early endosomes and increased the levels of C-terminal APP fragments
(APP-CTFs). By contrast, expression of the Numb isoforms with the insert in PTB (long PTB- or
LPTB-Numb) causes a significant reduction in the cellular content of APP and APP-CTFs.
4

Interestingly, when cultured primary cortical neurons were subjected to trophic factor
deprivation, the expression of the SPTB-Numb increased at the expense of LPTB-Numb,
suggesting that pathophysiological conditions can alter Numb isoform expression in a manner
that increases amyloidogenic processing of APP. Understanding the function of Numb in the
trafficking of APP may provide insights into the regulation of APP processing in AD
pathogenesis and lead to possible AD therapies.

5

Materials and Methods
Antibodies and reagents
Antibodies used for immunodetection of APP were 6E10 (anti-Aβ 1-17) and 22C11 (antisAPPα) (Chemicon); anti-amino terminus of APP (2.F2.19B4, Chemicon), anti-carboxyl
terminus of APP (APP643-695) and 4G8 anti-Aβ (17-24) (Signet). The polyclonal antibodies to
Numb were obtained from Santa Cruz (sc-15590) or Upstate (anti-pan-Numb). The antibodies to
Rab proteins were: Rab5a (Santa Cruz), Rab4a (Santa Cruz), Rab11 (Santa Cruz) and Rab7
(Sigma). LAMP-1 antibody was from Santa Cruz. Antibodies to the following tags were: GST
(glutathione S-transferase; Cell Signaling), HA epitope (Santa Cruz) and Flag epitope (Cell
Signaling). Other antibodies included: ERK1/2 and phospho-ERK1/2, (Cell Signaling),
dynamin1 (BD Biosciences), actin (Sigma), ubiquitin (Santa Cruz, P4D1), transferrin receptor
(Zymed), β-secretase 1 (BACE 1; Sigma), presenilin-1 (PS1; Chemicon), nicastrin (Sigma),
Aph-1 (Sigma), and Pen-2 (Santa Cruz). Immunofluorescence-conjugated secondary antibodies
(Alexa Fluor 488-conjugated goat anti-mouse and Alexa Fluor 594-conjugated rabbit anti-goat
IgG) were obtained from Molecular Probes. Additional reagents included: Lipofectamine Plus
reagent (Invitrogen), FuGENE-6 (Roche), EZ-Link Sulfo-NHS-LC-Biotin (Pierce), DAPT
(Calbiochem), lactacystin, peptide aldehyde N-carbobenzoxyl-l-leucinyl-l-leucinyl-l-leucinal
(MG-132), chloroquine (Calbiochem) and NH4Cl (Calbiochem). The ECL-Plus kit was obtained
from Amersham-Pharmacia Biotech. The β-amyloid 1–40 and 1–42 Colorimetric ELISA kit was
purchased from Biosource International Inc.

6

cDNA Constructs
Expression vectors for all four human Numb isoforms have been described previously 26,
27

. Full-length Numb, PTB deletion mutants of human Numb, or control expression plasmids

were constructed as in-frame fusions downstream of the FLAG epitope. The plasmid for the
dominant negative dynamin (dyn 1K44E tagged to HA and EGFP) was a kind gift from Dr. N.
Bunnett, University of California at San Francisco. The cDNA encoding dyn 1K44E was
subcloned into the retroviral vector pBabe-puro (Addgene). The construct was transfected
together with a plasmid encoding the vesicular stomatitis virus membrane glycoprotein (VSV-G)
envelope into 293T packaging cells (Clontech) using FuGENE-6, and the resulting viruscontaining supernatant was collected at 48 and 72 h after transfection, and used for transduction
as described 28. Expression of exogenous dyn 1K44E was confirmed by immunoblotting.

Cell lines and transfections
PC12, HEK293 and SH-SY5Y cells were cultured under standard conditions in DMEM
containing 10% fetal bovine serum (Invitrogen) and maintained at 37 °C in a 5% CO2/95% air
atmosphere. The PC12 cells stably expressing Numb variants have been described previously 27.
SY5Y neuroblastoma cells stably transfected with a construct carrying the AD disease-linked
double (“Swedish”) mutation K595N/M596L in APP were obtained from Dr. W. Araki (National
Institute of Neuroscience, Tokyo, Japan).

7

Treatments
Trophic factor withdrawal was accomplished by washing the cells twice with phosphatebuffered saline (PBS) and then maintaining them in Locke’s buffer 26. DAPT (2µM) was used to
inhibit γ-secretase activity. To inhibit proteasomes and lysosomes, cells were treated with
proteasomal inhibitors MG-132 (5 µmol/L) and clasto-lactacystin β-lactone (5 µmol/L), or the
lysosomal inhibitors chloroquine (100 µmol/L) and NH4Cl (50 mmol/L) for various time periods.
Inhibitors were resuspended either in dimethylsulfoxide (DMSO) or PBS. Controls were either
treated with equivalent volumes of DMSO for the proteasome inhibitors or with equivalent
volumes of PBS for chloroquine stimulations.

RNA isolation and PCR
Total RNA from cells grown on 100 mm dishes was isolated with Trizol (Invitrogen) and
2μg of RNA was reverse transcribed with Superscript II reverse transcriptase and an oligo-dT
primer. Quantitative real-time PCR (RT-PCR) analyses of APP, Numb and actin were performed
using the following pairs of primers: rat APP:5’-CCACTACCACAACTACCACTG-3’ (forward)
and

5’-CCTCTCTTTGGCTTTCTGGAA-3’

(reverse);

rat

β-actin:

5’-

TGTGATGGACTCCGGTGACGG-3’ (forward) and 5’-ACAGCTTCTCTTTGATGTCACGC3’ (reverse); Rab5A: 5’-AACAAGACCCAACGGGCCAAATAC-3’ (forward) and 5’ATACACAACTATGGCGGCTTGTGC-3’; PTB-Numb (forward): 5'-GGAAGTTCTTCAA
AGGCTTCTTTG-3'; PTB-Numb (reverse): 5'-TTCATCCACAACTCTGAGTCCATC-3'. The

8

Numb primers were designed to flank the alternatively spliced insert in the PTB domain of the
rat Numb cDNA sequence (Accession No: NM_133287).

SDS-PAGE and Western blotting
Cells were harvested and lysed in buffer (100 mM Tris, pH 6.8, 1% SDS, 10 mM EDTA,
5 mM EGTA, 2 mM PMSF, 25 µg/ml leupeptin, 5 µg/ml pepstatin). The lysates were cleared by
centrifugation at 13,000 g for 20 min at 4°C. The protein content of cell lysates was measured
using the bicinchoninic acid (BCA) reagent (Pierce). Extracts containing 50 µg of protein were
electrophoresed using Tris-HCl or 16.5 % Tris-Tricine SDS-PAGE (BioRad) under reducing
conditions and immunoblotted onto nitrocellulose membranes (Bio-Rad). For immunodetection
of blots, enhanced chemiluminescence (ECL, Amersham) was applied. The optical band
densities were quantified using NIH Image Analysis software.

Immunofluorescence microscopy
Following experimental treatments, cells were fixed for 20 min in 4% paraformaldehyde
in PBS at room temperature, permeabilized (or not) with 0.2% Triton X-100 in PBS, incubated
for 1 h in blocking solution (0.2 % Triton X-100, 5 % normal horse or goat serum in PBS) and
then with primary antibody for 1 h in blocking solution at room temperature. The cells were
washed with PBS and finally incubated with 1 μg / ml Alexa Fluor 488 goat anti-rabbit IgG
(1 μg / ml, Molecular Probes) in blocking solution at room temperature for 1 h. When double
labeling was required, cell preparations were incubated with Alexa Fluor 488-conjugated antimouse IgG and rabbit Alexa Fluor 594-conjugated anti-goat IgG (1:200). Immunostained cells
9

were observed with the appropriate filters on a Leica confocal laser scanning microscope;
average pixel intensity per cell was determined using software supplied by the manufacturer.
Appropriate controls, such as secondary antibody alone, indicated a lack of non-specific staining.

Measurements of sAPP levels
For detection of sAPP, the media were collected from cultures of PC12 clones and
centrifuged at 3,500g (10 min, 4 °C) to remove cell debris. The cleared supernatants were
concentrated at least 20 fold by ultrafiltration. Cells were harvested, lysed, and prepared for
protein determinations. Equal amounts of volumes of supernatants, standardized to lysates
protein, were subjected to SDS-PAGE and immunoblotting analyses. All conditioned media
values were normalized to total protein lysates.

Aβ40/42 sandwich enzyme-linked immuno-sorbent assay (ELISA) assay
SH-SY5Y cells expressing the Swedish mutant APP were transfected with plasmids for
the Numb variants or an empty pcDNA3 vector using Lipofectamine reagent according to the
manufacturer’s specifications. Conditioned media from transfected cells were collected 48 h after
transfection, and protein inhibitors and AEBSF (Sigma) were added to prevent the degradation of
Aβ. The concentration of Aβ40/42 in samples and standards was measured in duplicates using
the β-amyloid 1–40 and 1–42 colorimetric ELISA kit according to the manufacturer’s
instructions (Biosource).

10

Measurements of secretase activity
The activity of APP secretases was determined using commercially available secretase
kits (R&D Systems) according to the manufacturer’s protocol. The method is based on the
secretase-dependent cleavage of a secretase-specific peptide conjugated to the fluorescent
reporter molecules EDANS and DABCYL, which results in the release of a fluorescent signal
that can be detected using a fluorescence microplate reader (excitation at 355 nm /emission at
510 nm). The level of secretase enzymatic activity is proportional to the fluorimetric reaction.

Cell surface biotinylation
Confluent 10 cm dishes of each of the PC12 clones were washed three times with icecold PBS supplemented with 1 mM Ca2+ and 2 mM Mg2+, and incubated with 1 ml of biotin
label (Pierce EZ-Link Sulfo-NHS-Biotin) at 2 mg/ml for 0.5 h on ice in the dark on a rotary
mixer. The reaction was stopped by extensive washing with PBS and quenched with 50 mM
glycine in PBS. Cell lysates were then immunoprecipitated with strepavidin-coated agarose. The
precipitated biotinylated proteins were subjected to immunoblotting to analyze the content of
APP and transferrin receptor.

11

Results
Expression of Numb proteins alters APP metabolism in a manner dependent
upon the PTB domain.
To investigate the impact of Numb on APP metabolism, we stably overexpressed each of
the four human Numb proteins in PC12 cells

26, 27

. APP is physiologically processed by α-

secretase or β-secretase resulting in the shedding of nearly the entire ectodomain to yield large
soluble APP derivatives (called sAPPα and sAPPβ, respectively) and generation of membranetethered carboxyl-terminal fragments of APP (APP-CTFs) that include C83 and C99. The C99 is
further cleaved by γ-secretase to release the ~4 kDa Aβ peptide and the APP intracellular domain
(AICD). Stable expression of the SPTB-Numb proteins resulted in a significant accumulation of
intracellular APP (Fig. 4A) and increased secretion of sAPPα and sAPPβ in the conditioned
media (Fig. 4B). By densitometric scanning of Western blots, the total amount of APP
holoprotein in cells overexpressing the SPTB-Numb proteins was increased by four to five fold
compared to parental control cells and by eight to ten fold compared to the LPTB-Numb clones.
The increased accumulation of APP was confirmed by immunostaining using antibodies to the
amino- and carboxyl-termini of APP (Fig. 4B).
The intracellular accumulation of APP holoprotein coincided with a significant increase
in the amount of APP processing products. Both total sAPP and the amount of sAPPα
immunoprecipitated from the conditioned media with anti-APP antibodies 22C11 and 6E10,
respectively, were significantly higher in the SPTB-Numb clones. Steady-state levels of the αsecretase- and β-secretase derived APP-CTFs, C83 and C99, respectively, were also increased in
lysates, consistent with the ability of the SPTB-Numb proteins to promote non-amyloidogenic
and amyloidogenic processing pathways (Fig. 4B). The opposite effect was observed in the
12

clones expressing LPTB-Numb; steady state levels of APP holoprotein and APP processing
products were markedly reduced relative to the parental clones. Only with long exposure times
could the sAPP and APP-CTFs in the LPTB-Numb clones be detected. In contrast to APP, no
change in the total levels of the transferrin receptor (TfR; Fig. 4A) was found in the lysates
suggesting that the observed effects mediated by the Numb proteins were selective for APP.
Collectively, the data indicate that the Numb proteins that differ in the PTB domain affect the
processing of APP in a distinct and contrasting manner.

Expression of Numb proteins alters Aβ generation in a manner dependent upon
the PTB domain.
Since the Numb proteins differentially affect APP cleavage and the generation of APPCTFs, we reasoned that Numb should also influence the generation of Aβ. To test this notion, the
cDNAs encoding Flag-Numb variants were transfected into SY5Y cells expressing the Swedish
mutant APP (Fig. 4C). Aβ40 and Aβ42 levels in the conditioned medium 48 h after transfection
were determined using ELISA measurements. Consistent with the observed effects of Numb on
the generation of APP-CTFs, we found that the LPTB-Numb proteins suppressed the production
of Aβ40 and Aβ42 into the conditioned medium, whereas cells expressing the SPTB-Numb
proteins generated elevated levels of Aβ40 (7.3 pg/ml versus 28.5 pg/ml/protein) and Aβ42 (3.4
pg/ml/protein versus 13.2 pg/ml) normalized to the total protein amount (Fig 4C).
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Figure 4. Isoform specificity in the processing of APP and generation of Aβ by the Numb
proteins.
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(A) Effect of Numb proteins on the amounts of APP and TfR. Representative
immunoblot showing total levels of APP and TfR protein in the indicated PC12 clones (left
panels). Each lane was loaded with 50 µg of protein. The relative amounts of APP and TfR were
normalized to those of actin. Densitometric analyses were performed on the immunoblots (right
panel). The values in the histogram represent the mean ± SD n = 3; *p < 0.01; #p < 0.05
(ANOVA with Scheffe post-hoc tests) relative to empty vector-transfected cells. (B) Effect of
Numb proteins on the cleavage of APP. APP derivatives in the conditioned medium and in
lysates of the indicated PC12 clones were quantified by western blot followed by densitometric
analyses. APP derivatives in conditioned culture medium were immunoprecipitated with an
antibody to the amino terminal domain of the APP protein (22C11 which precipitates both
sAPPα and sAPPβ and an antibody to Aβ (6E10; Signet) which recognizes sAPPα. Steady-state
levels of membrane-associated APP derivatives, C99 and C83, were immunodetected with
antibodies to the carboxyl terminal domain of the APP protein. The β-actin signal represents the
internal loading control. Densitometric analyses were performed on the immunoblots (left panel).
The values in the histogram represent the mean ± SD; n = 3; * p < 0.01; # p < 0.05 (ANOVA
with Scheffe post-hoc tests) relative to vector-transfected control. Essentially similar results were
obtained using two additional stable clones. (C) Effect of Numb proteins on the generation of Aβ
peptides. SY5Y cells stably expressing the Swedish mutation of APP were transfected with
plasmids encoding the Flag-Numb proteins. Conditioned media were harvested and analyzed by
a sandwich-ELISA for specific quantization of Aβ40 and Aβ42. Expression of Flag-Numb
proteins was detected by immunoblotting using an antibody to Flag (left panels).The histogram
shows the amounts of Aβ40 and Aβ42 in the indicated clones (right panels). The values represent
the mean ± SD; n = 3;*p < 0.01; #p < 0.05 (ANOVA with Scheffe post-hoc tests) relative to
vector-transfected cells.
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Expression of the Numb proteins does not affect the level of APP expression nor
the proteolytic activities of the APP processing secretases.
One possible explanation for the effects of Numb on APP metabolism would be an
alteration in the expression of APP. The presence of the Numb proteins had no significant effect
on the levels of APP mRNA (Fig. 5A). We also considered the possibility that the Numb
proteins might differentially alter the activities or the amounts of the APP processing secretases.
To investigate the influence of the Numb proteins on APP cleavages, we analyzed the proteolytic
activities of α-, β-, and γ-secretases using commercially available secretase kits from R&D
Systems. No significant difference in the proteolytic activities of these secretases was detected
among the stable clones (Fig. 5B). In addition, we found that levels of BACE1 and of the γsecretase components (presenilin-1, nicastrin, APH-1, APH2) were not altered by the expression
of Numb (Fig. 5C) which further argued against a role of the Numb proteins in regulating the
proteolytic activities of the secretases. Collectively, the data suggest that Numb proteins do not
alter APP metabolism by regulating the expression of APP or the enzymatic activities of the
secretases.
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Figure 5. Lack of isoform specificity on the expression of APP and the activities of the APP
secretases
(A) Expression of the Numb proteins did not alter the expression of APP. Semiquantitative RT-PCR analysis of APP mRNA in the indicated PC12 clones (left panels). The
GAPDH signal represents the internal loading control. The values in the histogram are the mean ±
SD of 3 independent measurements (right panel). Essentially similar results were obtained using
two additional stably transfected clones. (B) Expression of the Numb proteins did not alter the
activities of APP processing secretases. The lysates were tested for secretase activities by
addition of secretase specific peptide substrates conjugated to the reporter molecules EDANS
and DABCYL (R&D). Fluorescently labeled peptides were detected only upon cleavage by the
respective secretases. After incubation at 37 °C for 2 h, reactions were transferred to a 96-well
plate, and fluorescence was measured as described under "Experimental Procedures". The values
expressed as arbitrary units of fluorescence (AUF), are the mean ± SD of at least 3 independent
experiments. (C) Numb proteins did not alter the protein level of β-secretase (BACE1) and of the
components of the γ-secretase complex. Representative immunoblots showing total levels of βsecretase, presenilin-1, nicastrin, Aph-1, and Pen-2 in the indicated clones. Each lane was loaded
with 50 µg of protein. Blots were reprobed with an antibody against actin to confirm equal levels
of protein loading among samples.
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The effects of Numb on APP metabolism is dependent on its interaction with
APP and the internalization of APP
Because the interaction of APP with Numb requires the YENPTY motif interacting with
the PTB domain

24

, we determined the effects of a Numb deletion mutant lacking the PTB

domain (ΔPTB-Numb) on APP metabolism. Quantification of the Western blots (normalized to
actin) revealed that APP metabolism was not altered in the presence of the ΔPTB-Numb protein
(Fig. 6A) suggesting that the PTB domain is required for the Numb proteins to influence APP
metabolism. To determine if the Numb proteins affect the proteolytic processing of APP by
targeting APP along the endocytic rather than the secretory routes, we examined the effects of a
dominant negative mutant dynamin (dyn 1K44E tagged to the hemagglutinin epitope (HA) and
EGFP; a gift from N. Bunnett, U of California at San Francisco) on the ability of each Numb
protein to modulate APP metabolism. The GTPase dynamin is an important mediator of clathrin
dependent endocytosis and is required for the internalization of many cell surface receptors
including Notch and APP

7, 29

. As expected, inhibition of endocytosis by mutant dynamin

induced an elevation of APP holoprotein in all the clones including the LPTB-Numb clones (Fig.
6B). Total APP protein level in the SPTB-Numb and LPTB-Numb clones was not significantly
different compared to those in the vector-transfected and parental clones. These results indicate
that the Numb proteins differentially affect the processing of APP along the endocytic route.

Numb proteins influence the endosomal trafficking of APP
APP undergoes a retrograde transport back to the cell body wherein it is localized in
Rab5a positive early endosomes 30, late endosomes 8, 31, lysosomes 6 and the Golgi-complex 8. To
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determine whether the Numb proteins affect the transport of APP to these intracellular
compartments, we applied immunofluorescence microscopy to examine the subcellular
localization of APP and Numb. Both these proteins are colocalized on the plasma membrane and
in vesicular structures in PC12 cells (Fig. 6C). Expression of the SPTB-Numb proteins resulted
in a marked accumulation of APP in enlarged endosomes (Fig. 6D) that were positively labeled
for Rab5a (Fig. 6E). Increased APP immunoreactivity was also detected in Rab11-labeled
recycling endosomes (data not shown) but not in LAMP1-labeled lysosomal compartments of the
SPTB-Numb clones (data not shown). The subcellular location of APP was similar to that of
Numb suggesting that Numb interact with APP in the early endocytic compartments. By
contrast, APP was only faintly detected in the Rab5- (Fig. 6D), Rab11-, and LAMP1-labeled
compartments (data not shown) in LPTB-Numb clones. Collectively, these data suggest that the
PTB domain of Numb determines the processing fates of APP by regulating its endosomal
sorting and trafficking to distinct compartments.
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Figure 6. Isoform specificity of Numb effects on APP metabolism is dependent on the
interaction of the Numb proteins with APP and its subsequent internalization
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(A) Expression of a Numb protein lacking the PTB domain (ΔPTB-Numb) did not alter
APP metabolism. Representative immunoblot showing total levels of APP holoprotein in the
indicated PC12 clones (left panels). Each lane was loaded with 50 µg of protein. APP was
quantified by western blot with an antibody to the amino terminal domain of the APP protein
followed by densitometric analyses (right panel). The relative amounts of APP were normalized
to those of actin. (B) Inhibition of endocytosis by overexpression of mutant dynamin (dyn)
1K44E abolished the effects of the Numb proteins on APP metabolism. Twenty-four hours after
transduction, cell lysates were analyzed by immunoblotting followed by densitometry (right
panel). Representative Immunoblot showing total levels of APP in the indicated PC12 clones.
Overexpression of the dyn1K44E was confirmed using antibodies raised to dyn1 and to the HA
tag. The β-actin signal represents the internal loading control. The values in the histogram
represent the mean ± SD n = 3; *p < 0.01; #p < 0.05 (ANOVA with Scheffe post-hoc tests)
relative to vector-transfected cells. (C) Localization of APP and Numb in PC12 cells by confocal
immunofluorescence microscopy. Following fixation and permeabilization, rabbit anti-Numb
and goat anti-rabbit conjugated FITC, and mouse anti-APP (22C11) and goat anti-mouse
conjugated CY3 secondary antibody were used to detect Numb and APP protein, respectively.
The right panel shows the merged image of APP and Numb. (D). Intracellular accumulation of
APP and membrane-associated APP derivatives in a SPTB-Numb (left panel) and LPTB-Numb
clone (right panel). Following fixation and permeabilization, APP was detected with antibodies
to the carboxyl terminal domains of the APP protein. (E) Localization of APP to endocytic
compartments by confocal immunofluorescence microscopy. Following fixation and
permeabilization, rabbit anti-Rab5A and goat anti-rabbit conjugated FITC were used to detect
the early endosomes (green signal), and mouse anti-APP (22C11) and goat anti-mouse
conjugated CY3 secondary antibody were used to detect APP protein (red signal). The right side
of each image shows the merged image of APP and Rab5, depicting early endosomes. The
images are representative of those obtained from at least three stably transfected clones.
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Effect of the Numb proteins on the endosomal sorting of APP to the recycling
pathway
In spite of the accumulation of APP in the enlarged early endosomes (Fig. 6D), SPTBNumb clones exhibited increased release of sAPPα and generation of C83 suggesting that APP
may be preferentially sorted from the early endosomes back to the cell surface where APP is
cleaved by α-secretase. To evaluate the amount of APP localized on the cell surface, we
performed cell membrane staining for APP on ice without permeabilization. Only a small
fraction of APP was detected at the cell surface of parental cells not permeabilized prior to
antibody incubation (Fig. 7A), consistent with a previous report 5. The fraction of cell surfacebound APP was markedly higher in the SPTB-Numb clones. As expected, this fraction was
significantly lower in the LPTB-Numb clones compared to parental cells. As another measure of
surface APP protein level, proteins on the cell surface were biotinylated with a cell impermeable
cross-linker, collected with strepavidin-coupled beads, and subjected to immunoblotting. As
expected, the level of biotinylated plasma membrane-bound APP was significantly higher in
SPTB-Numb clones (Fig. 7B). By densitometric scanning of Western blots, the amount of cell
surface-localized APP relative to TfR was approximately five folds higher in cells
overexpressing SPTB-Numb compared to vector-transfected cells (Fig. 7C). None of the
biotinylated fractions contained actin consistent with the labeling of only cell surface bound
proteins (Fig. 7B).
To determine whether vesicle recycling contributed to the increased cell surface
expression of APP in the SPTB-Numb clone, we assessed the impact of a blockade in the
endosome recycling pathway. Preincubation with monensin, an established inhibitor of the
recycling pathway that does not interfere with the initial endocytosis of surface receptor proteins
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32

, significantly depleted cell surface APP expression as assessed by surface biotinylation

followed by immunoblotting of the isolated biotinylated fraction (Fig. 7D). The surface receptor
depleting effect of monensin on TfR was only slightly reduced in the absence of ligand (Fig. 7D)
suggesting that the recycling pathway of APP may be mechanistically distinct from that of TfR.
Quantification of the immunoblots revealed that the changes in the ratio of APP to TfR after
treatment with monensin was significantly greater in the SPTB-Numb clone compared to the
vector-transfected cells (Fig. 7E).
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E

α-APP
(non- permeabilized)

Figure 7. Effect of the Numb proteins on the sorting of APP to the recycling pathway
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(A) The Numb proteins differentially alter the amount of cell surface APP.
Immunostaining of cell surface APP with an antibody to the amino terminal end of APP. In nonpermeabilized cells (without Triton X-100), significantly more APP is detected on the surface of
a SPTB-Numb clone compared to a LPTB-Numb clone or a clone transfected with empty vector.
(B) Detection of cell surface APP by biotinylation. Cells were surface biotinylated, lysed, and
incubated with strepavidin-agarose beads. Biotinylated proteins were immunoblotted with
antibodies to APP and TfR. (C) Quantitative data showing the ratio of cell surface APP and TfR
in the indicated clones. Values are the mean ± SD of at least 3 independent
experiments.*p <0.01; #p< 0.05 (ANOVA with Scheffe post-hoc tests) relative to vectortransfected cells. (D) Recycling blockade depletes cell surface APP protein level. The indicated
clones were pretreated with monensin for 60 min at 37°C in DMEM/BSA and incubated in
DMEM/BSA for 60 min afterwards. Cells were then surface biotinylated using a membraneimpermeable cross-linker and immunoprecipitated with strepavidin beads. Precipitates were
subjected to SDS-PAGE, and blots were probed with antibodies to APP and TfR. (E)
Quantitative data showing the changes in the ratio of cell surface APP and TfR in the vectortransfected and a SPTB-Numb clone after monensin treatment. Values are plotted as percent of
untreated control (vehicle) and are the mean ± SD of at least 3 independent experiments. *
p < 0.05 (Student’s t test) relative to vector-transfected cells.

Effects of the Numb proteins on the endosomal sorting of APP to the degradative
pathway
To further establish that altered subcellular localization of APP is responsible for the
differences in its processing fates in the Numb clones, we treated PC12 clones with chloroquine,
a weak base known to disrupt lysosomal function by blocking organelle acidification

33

.

Treatment with chloroquine (100 µM) for up to 6 h (Fig. 8A) and longer (data not shown) had no
marked effects on the levels of APP (Fig. 8A) and APP-CTF derivatives (data not shown) in
SPTB-Numb clones. Similar results were obtained in the presence of ammonium chloride
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(NH4Cl; 50 mmol/L) confirming that the available pools of APP in the SPTB-Numb cells were
absent from the lysosomes (Fig. 8B). By contrast, levels of APP protein (Fig. 8A) and APP-CTF
derivatives (data not shown) in LPTB-Numb clones were significantly increased following
chloroquine treatment in comparison to vector-transfected cells, ruling out the possibility that
chloroquine at the concentration of 100 µM was too low to induce APP accumulation in the
SPTB-Numb clone (Fig. 8A). The same dose of chloroquine also caused marked accumulation
of APP and APP-CTFs in SH-SY5Y cells stably transfected with the empty vector or with the
Swedish mutant APP (Fig. 8C). The effect of lysosomal inhibitors on APP protein levels was
dose-dependent (data not shown). Control incubation of PC12 clones with PBS resulted in
unchanged levels of APP (data not shown). To determine that the chloroquine-induced increase
in APP holoprotein was not related to an effect of Numb on the synthesis of APP, we treated
cells with the protein synthesis blocker cycloheximide (10 µg/mL) in combination with
chloroquine. Treatment with cycloheximide for 6 h did not prevent the chloroquine-induced
increase in APP holoprotein (data not shown).
In contrast to lysosomal inhibitors, we found that treatment with the γ-secretase
inhibitor DAPT markedly enhanced steady state levels of APP and APP-CTFs in the SPTBNumb clone (Fig. 8D). The APP-CTFs were only weakly detected in the vector cells but became
clearly visible, as in the untreated SPTB-Numb clones, after treatment with DAPT which halted
the cleavage of membrane associated APP-CTFs. The effect of DAPT on APP protein levels was
dose-dependent (data not shown). In contrast, DAPT failed to elevate levels of APP-CTFs in the
LPTB-Numb clones. Collectively, our data indicate that the Numb proteins target APP to
endocytic compartments with distinct APP processing outcomes.
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The proteasome-mediated degradative pathway is not involved in the regulation
of APP metabolism by the Numb proteins
Considerable evidence indicates that Numb antagonizes Notch signaling transduction by
activating the endocytic uptake and degradation of the Notch protein via the proteasomal
degradation pathway

19, 34

. Because of the striking similarities in the proteolytic processing of

Notch and APP, we hypothesized that the LPTB-Numb proteins may reduce APP protein levels
by facilitating proteasomal-mediated degradation of APP. To test this hypothesis, we treated the
stable clones with lactacystin, which inhibits proteasomal degradation of proteins by specifically
targeting the 20S proteasome, without interfering with lysosomal protein degradation

35

.

Treatment with lactacystin did not result in significant changes in APP protein levels and did not
impact the generation of APP metabolites in any of the clones tested (Fig. 8E) suggesting that
the differential effects of the Numb proteins on APP metabolism did not involve the ubiquitinproteasome protein degradation pathway. Higher concentrations of lactacystin did not
significantly induce APP accumulation although the dose of 10 µM was sufficient to induce
enrichment of ubiquitinated protein species in general, as shown in Western blot analysis
conducted with an antibody to ubiquitin (data not shown). Collectively, the data indicate that the
drastic reduction in APP protein level in the LPTB-Numb clones was not due to Numb-mediated
targeting of APP for proteasome-dependent degradation.
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Figure 8. Effect of the Numb proteins on the sorting of APP to the degradative pathway
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(A) Time course of the accumulation of APP and APP-CTFs in LPTB-Numb but not

SPTB-Numb clones after treatment with a lysosomal inhibitor. The indicated stable PC12 clones
were treated with chloroquine (100 µM) for 0, 2, and 6 h. Equal amounts of cellular lysates were
separated by 16.5% Tris-Tricine SDS-PAGE and immunoblotted with an antibody to the
carboxyl terminal of APP. β-actin was used as the internal loading control. Densitometric
analyses were performed on the immunoblots (bottom panel). The values in the histogram are the
mean ± SD of 3 independent measurements. *p< 0.01, #p<0.05 (ANOVA with Scheffe post-hoc
tests) relative to vector-transfected cells. Similar results were obtained using two additional
stably transfected Numb clones. (B) Time course of the accumulation of APP in LPTB-Numb
but not SPTB-Numb clones upon treatment with NH4Cl. The indicated clones were treated with
NH4Cl (50 µM) for 0, 2, 6, and 8 h and processed for immunoblotting using an antibody to the
carboxyl terminal of APP. (C) Time course of the accumulation of APP and APP-CTFs in SHSY5Y cells overexpressing the empty-vector (Vector) or a vector encoding the Swedish mutant
APP (APP) upon chloroquine treatment. The indicated SY-SY5Y clones were treated with
chloroquine (100 µM) for 0, 2, and 6 h. Each lane was loaded with 50 µg of protein. β-actin was
used as the internal loading control. (D) Time course of the accumulation of APP in the SPTBNumb but not LPTB-Numb clones after treatment with the γ-secretase inhibitor DAPT. The
indicated clones were treated for 0, 2, 6, and 12 h with 10 µM DAPT. Each lane was loaded with
50 µg of protein. β-actin was used as the internal loading control. Densitometric analyses were
performed on the immunoblots (bottom panel). Values are the means ± SD of 3 independent
measurements. *p< 0.01 (ANOVA with Scheffe post-hoc tests) relative to empty vector
transfected cells. (E) Inhibition of the proteasomes failed to affect the regulation of APP
metabolism by the Numb proteins. Time course of the levels of APP and APP-CTFs in the
indicated clones after treatment with 10 µM lactacystin. Equal amounts of protein from each
sample were immunoblotted to detect APP and APP-CTFs. Each lane was loaded with 50 µg of
protein and verified with an antibody to actin. Essentially similar results were obtained using two
additional stably transfected Numb clones.
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Expression of Numb proteins alters the levels of the Rab family of endocytic
regulators
Recent studies have demonstrated the involvement of GTP-binding proteins of the Rab
family in the trafficking and processing of APP

36, 37

. Rab proteins are localized in both discrete

organelles and vesicles where they play key roles in protein trafficking between compartments
along the secretory and endocytic routes. To determine whether the differential endosomal
sorting of APP resulted from the altered expression of Rab proteins, we measured protein levels
of Rab4, Rab5A, Rab7, and Rab11. Rab5A is a small GTPase localized on early endosomes and
controls endosome fusion along the endocytic pathway. Rab4A and Rab11 are regulators of the
recycling endosomes

36, 37

. Protein levels of Rab4A, Rab5A and Rab11 were significantly

increased in the SPTB-Numb clones relative to control cells (Fig. 9A, B). By contrast, levels of
Rab5A and Rab11 were decreased in the LPTB-Numb clones relative to control cells (Fig. 9A,
B). Levels of Rab7, a regulator of fusion events in the late endocytic pathway, and of LAMP-1, a
lysosome-associated membrane protein-1 were not different among the stable clones (Fig. 9A,
B). The changes in the level of the Rab5A protein were not attributable to altered expression as
its mRNA level was not significantly different in the stably transfected Numb clones (Fig. 9C).
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Figure 9. Effect of the Numb proteins on the levels of small Rab GTPases
(A) Representative Immunoblots showing total amounts of Rab4A, Rab5A, Rab7,
Rab11, and LAMP1 in the indicated clones. Each lane was loaded with 50 µg of protein and
verified with an antibody to actin. (B) Densitometric analyses were performed on the
immunoblots shown in (A). The values in the histogram are the mean ± SD of 3 independent
measurements.*p< 0.01, #p<0.05 (ANOVA with Dunnett’s Multiple Comparison Test). (C)
Semi-quantitative RT-PCR analysis of Rab5A mRNA in the indicated PC12 clones. The
GAPDH signal represents the internal loading control.

Stress induces the selective upregulation of SPTB-Numb transcripts
It has been previously reported that alternative splicing of Numb primary transcripts is
developmentally regulated

37, 38

. To determine whether the balance of the alternative spliced

variants of Numb might be disrupted in cells that were stimulated by apoptosis-inducing agents,
we designed oligonucleotide primers that bind to the flanking sequences of the insertion in the
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PTB domain (Fig. 10A). The expected sizes of the amplified PCR products for the SPTB- and
LPTB-Numb transcripts were 114 and 147 base pairs, respectively. The level of LPTB-Numb
mRNA which is predominantly expressed under basal condition decreased rapidly upon trophic
factor withdrawal (TFW), an insult that has previously shown to alter Numb expression

26

,

whereas that of SPTB-Numb accumulates in parallel in stressed cells (Fig. 10B,C). Protein but
not mRNA levels of APP were also increased in PC12 cells subjected to TFW (data not shown).
Collectively, these data suggest that cellular could induce the selective upregulation of SPTBNumb proteins which precedes the accumulation of APP protein.
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Trophic Factor
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Figure 10. Detection of alternatively spliced Numb transcripts under normal and stressed
conditions
(A) Domain structure of the Numb protein. The 11 amino acid insertion in the PTB
domain is indicated in black. The forward (F) and reverse (R) primers were designed to amplify
a region flanking the PTB insertion. The specificity of the primer set was confirmed by
performing PCR using an empty plasmid (pCDNA3.1) or plasmids containing each of the four
Numb isoforms. The expected sizes of PCR fragments were 114 and 147 base pairs for the
SPTB- and LPTB-Numb transcripts, respectively. (B) Time course of SPTB-Numb and LPTBNumb mRNA levels in PC12 cells subjected to trophic factor withdrawal. (C) Densitometric
analyses were performed on the data shown in (B). The values in the histogram are the mean ±
SD of 3 independent measurements.*p< 0.01 (Student’s t-test) relative to untreated control PC12
cells.
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Discussion
Alterations in the endosomal-lysosomal system are believed to occur early in the disease
process in AD, and may precede the formation of plaques and tangle-associated neuropathology
in susceptible neuron populations. Endosome enlargement occurs early in sporadic AD, and is
associated with increased endocytosis and endosome recycling. Aβ immunoreactivity is evident
in these populations of enlarged endosomes prior to Aβ deposition indicating their potential
importance for Aβ formation in early AD brain. Much attention has focused on the mechanisms
that regulate the trafficking of APP to endosomes. In this study, we have uncovered a novel
function for the Numb adapter proteins as a regulator of endocytic trafficking of APP. Most
surprisingly, we found that the Numb proteins that differ in the PTB, but not in the PRR domain,
have opposite effects on the transport and processing of APP. The expression of SPTB-Numb
proteins resulted in a significant accumulation and persistence of APP holoprotein in the early
endosomes and increased Aβ secretion. By contrast, expression of LPTB-Numb proteins
significantly decreased the accumulation of APP and inhibits Aβ secretion. The reduction in Aβ
secretion was not the result of either the decreased expression of APP or a significant reduction
in the activities of the APP processing secretases. Furthermore, we demonstrated that all the
Numb isoforms were capable of interacting with the APP holoprotein, as reported by a previous
study 24. The APP lowering effect was related to the trafficking role of the LPTB-Numb proteins
along the endocytic rather than the secretory pathway as treatment with lysosomal inhibitors was
able to restore endogenous APP holoprotein to the steady state level found in vector-transfected
cells. It is conceivable that LPTB-Numb but not SPTB-Numb proteins facilitate the delivery of
APP to the lysosomes for degradation by acidic hydrolases. Taken together, these results indicate
that APP trafficking differs strikingly in the clones stably expressing the Numb proteins and raise
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the intriguing possibility that alternative splicing of Numb could alter the trafficking of APP and,
concomitantly, its processing fate.
Numb was discovered as an intracellular Notch antagonist

15, 17

. Considerable evidence

over the past years indicated that Numb antagonizes Notch1 signaling by inducing Notch1
ubiquitination and endocytic degradation of NICD

19, 35

. Genetic and biochemical evidence in

invertebrates has suggested that proteasomal degradation of Notch may be required for the
cessation of Notch signaling

19, 35

. Numb has been shown to recruit the E3 ubiquitin ligase to

facilitate Notch receptor ubiquitination 19. Several E3 ubiquitin ligases such as LNX, Itch, Siah1,
and Mdm2 have been shown to associate with Numb 19, 39, 40. To exclude the possibility that the
LPTB-Numb target APP for proteasomal degradation, we found that proteasomal inhibition had
no marked effect on the accumulation of APP in the stable clones examined suggesting that
Numb did not target APP for proteasomal degradation.
The PTB domain is a protein-protein interaction motif that has been identified in diverse
group of proteins, of which only a subset is linked to tyrosine kinase-mediated signaling

41

.

Structure-function analyses indicated that the Numb PTB domain can bind to multiple
conformationally distinct peptide ligands in a phosphotyrosine-independent manner

42-44

. The

PTB domain of Numb has been shown to interact with diverse proteins that determine its
subcellular localization

42

and protein stability

45

. The PTB domain of Numb mediates the

interaction with the E3 ubiquitin ligases responsible for the ubiquitination of its bound substrates
such as Notch and Gli

15, 19

. Hence, the presence or absence of the insertion within the PTB

domain could impact the interaction of the Numb proteins with E3 ligases and the targeted
substrates

15, 46

. We found that the insert in the PTB domain did not affect the ability of the

Numb proteins to interact with APP, in accord with a previous study showing that APP was
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found in complex with all four mammalian Numb isoforms in cortical lysates

24

. The present

study showed that Numb can bind directly to the YENPTY motif in the cytoplasmic domain of
APP, an interaction that is not only required for the internalization of cell surface APP, but also
for its subsequent transport and processing fate.
The accumulation of APP holoprotein did not correlate with a reduction of Aβ secretion
which supports the contention that the Numb proteins influence the trafficking of endogenous
APP along endocytic rather than secretory routes. Additional data showed that inhibition of
endocytosis by overexpression of a dominant-negative dynamin negates the observed effects of
the Numb proteins on APP metabolism. Furthermore, treatment of the Numb clones with
Brefeldin A to inhibit the transport of proteins from ER to Golgi did not show any effect on APP
accumulation (data not shown) whereas lysosomal inhibitors restored steady state levels of APP
in the LPTB-Numb clones.
The reduced sensitivity of the SPTB-Numb clones to inhibition of lysosomal degradation
suggests that these Numb proteins may interfere with the transport of APP to the degradative
pathway. Alternatively, we can not rule out the possibility that these Numb proteins play an
active role in recycling internalized APP back to the cell surface. This notion is consistent with
the increased amounts of released sAPPα and intracellular C83 generated by α-secretase
cleavage which occurs mainly at the cell surface. As dissociation of protein-protein complexes
favors the recycling pathway, it remains to be elucidated whether the interaction of the Numb
proteins and APP resulted in conformational changes that are differentially resistant to
decreasing pH values within the endosomal pathway. Regardless of the underlying molecular
mechanisms, our data suggest that the Numb proteins differentially alter the endocytic trafficking
of APP by regulating the endosomal sorting of this protein either to the degradative or recycling
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pathway. It will be interesting to examine whether the Numb proteins differentially affect the
trafficking of other receptors with the conserved YENPTY motif such as TrkA, a tyrosine kinase
receptor whose protein level and responsiveness to nerve growth factor (NGF) were shown to be
differentially affected by the Numb proteins 27.
Whether the Numb proteins are directly involved in the active transport of APP remains
to be elucidated. Intracellular trafficking through the endocytic and recycling pathway are
regulated by the small GTPase Rab proteins whose altered expression and activity has been
linked to altered APP metabolism 36, 47, 48. Rab5A upregulation is associated with enlarged early
endosomes and intracellular accumulation of APP

48

. Altered Rab5A activity is responsible for

the early abnormalities of the neuronal endocytic pathway that are directly related to a rise in Aβ
levels in brains of AD patients 47, 48. Previous studies demonstrated that Numb interacts with Arf6
and EHD4 49, proteins that have been associated with the recycling of plasma membrane proteins
internalized by clathrin-dependent and clathrin-independent endocytic routes 50. Impairments in
the sorting pathway could also account for the intraneuronal Aβ accumulation in the brains of
APP mutant transgenic mice and human AD patients 51. We found that level of Rab5A protein
but not mRNA was elevated in the SPTB-Numb clones suggesting that altered Rab5A function
in part correlates specifically with altered trafficking of APP. The mechanism(s) whereby
expression of SPTB-Numb but not increases Rab5A protein level remains to be established.
At present, the factors that regulate the alternative splicing of the primary Numb
transcript are not known. It has been shown that the four Numb isoforms are temporally
regulated and implement distinct developmental functions

37, 38

. Ectopic expression of Numb

isoforms lacking the PRR insertion promotes differentiation whereas those isoforms with the
insertion direct proliferation. Indeed, the expression of LPRR-Numb isoforms that promote
35

proliferation peaks during the expansion of the neural progenitor pool but is downregulated
during the course of neuronal development

37, 38

. The expression pattern of the Numb proteins

also varies dramatically between different tissues and cultured cell lines suggesting that Numb
isoforms may have different functions in different cell types. Our previous study demonstrated
that Numb protein levels increased in Aβ laden brain regions of a mouse model of AD 26. In this
study, we found for the first time that pathophysiological conditions can upregulate the
expression of SPTB-Numb at the expense of LPTB-Numb. This finding raises the intriguing
possibility that altered Numb expression is an early pathologic event that may be responsible for
increased Aβ production in patients with AD.
Although the exact function of APP is still not resolved, experimental evidence suggests
several activities including synaptogenesis, neurite outgrowth, and cell survival in neurons 1. All
of these activities may potentially be affected by the presence of Numb proteins determining the
processing fates of APP. Of particular note is that overexpression of SPTB-Numb in PC12 cells
enhanced neurite outgrowth

27

and increased vulnerability to apoptotic stimuli by a mechanism

dependent on the dysregulation of intracellular Ca2+ homeostasis

26, 27

. How Numb modulates

intracellular Ca2+ homeostasis remains to be elucidated. The disruption in Ca2+ signaling may be
linked to altered APP metabolism

1, 52

suggesting the involvement of altered Numb function or

expression in the genesis of the AD phenotype. Hence, perturbation of Numb expression may
have important implications for AD pathogenesis.
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Figure 11. Schematic diagram: Numb isoform-specific regulation of APP trafficking and
Aβ generation
At the pro-neuronal PC12 cells, stress induces the alternative splicing of numb proteins
that differ at the PTB domain favoring the upregulation of the SPTB isoform. Increases in the
SPTB isoform of Numb regulates the endocytic trafficking of APP by preferentially shorting
APP at the early and recycling endosomes. The accumulation of APP at these distinct endocytic
compartments is accompanied by increased proteolytic processing by β- and γ- secretases and
increased generation of Aβ at the condition media.
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CHAPTER II
EFFECTS OF NUMB ISOFORMS ON NOTCH-DEPENDENT
UPREGULATION OF TRPC6 CALCIUM CHANNELS
Introduction
Numb was first identified in Drosophila as an asymmetrically localized protein involved
in neural development

10, 53

, playing a key role in maintaining neural progenitor cells and

preventing premature neuronal differentiation

54

. Notch is a type-I cell surface receptor that

regulates cell fate decisions during neurogenesis

55

.

Numb accomplishes its effects by

antagonizing Notch signaling pathways 56, 57 via a mechanism that may involve Numb-mediated
ubiquitination of Notch and subsequent degradation of Notch intracellular domain (NICD)

58

.

Mammalian homologues of Numb have been identified suggesting an evolutionary conserved
function of Numb

54, 59-62

. During mouse cortical neurogenesis, Numb is also asymmetrically

localized, suggesting its potential role in the mammalian nervous system 61. However, Numb is
also expressed in many adult tissues, suggesting that its functions are not limited to neurogenesis
57, 60

. Structurally, Numb possesses an N-terminus phosphotyrosine binding (PTB) domain

proline-rich C-terminus region (PRR) containing SH-3 domain binding sites
homology (EH) domain binding motif

64

60

63

,a

, and an Eps15

. Mammalian Numb is expressed in four isoforms

differing in the length of the PTB (lacking or containing an 11 amino acid insert) and PRR
(lacking or containing a 48 amino acid insert) domains 59. Numb proteins containing an insertion
in the PRR region (LPRR) promote proliferation of neural crest cells, while those lacking the
insert (SPRR) appear to mediate neural differentiation 65. These results suggest that the functions
of Numb proteins may be isoform-specific and should be studied separately. PC12 cells stably

38

expressing the Numb isoform that is lacking the PTB insert (SPTB-Numb) stimulate NGFinduced differentiation and enhance apoptosis induced by NGF deprivation compared to cells
that stably express the isoform with the PTB insert (LPTB-Numb) 27. The role of PTB isoforms
in cell fate decisions has been further supported by finding where the SPTB-Numb exhibit
enhanced elevations of intracellular concentration of calcium ([Ca2+]i) and increased cell death
sensitivity in response to long-term exposure to amyloid-β peptide (Aβ)

26

. The mechanism by

which Numb modifies calcium homeostasis in SPTB-Numb is not clear, but considering the
enhanced calcium responses to bradykinin, a know IP3 activator, it may involve enhanced release
of calcium from endoplasmic reticulum (ER) stores 26.
The critical role of calcium in many diverse cellular processes including muscle
contraction, cell death and proliferation, signal transduction and transcriptional regulation has
been established

66

. Calcium is an important intracellular messenger that mediates many

physiological responses in neurons

67

. During normal physiological states, calcium signaling is

initiated by transient increases in [Ca2+]i that emerge either by calcium entry into the cell from
the extracellular space and/or by calcium release from the intracellular stores (i.e. ER),

68

.

However, ample data suggest that perturbations of calcium homeostasis are involved in the
pathogenesis of several neurodegenerative disorders and stroke 69. A variety of different classes
of calcium channels are found in the plasma membrane, which open in response to voltage-,
second messenger-, receptor-, or store-operated mechanisms 70. The transient receptor potential
canonical (TRPC) calcium channels are one of the seven members of the TRP superfamily which
are further divided into four subfamilies on the basis of sequence homology: TRPC1, TRPC2,
TRPC3/6/7 and TRPC4/5 71. TRPC channels are non selective cation channels that are activated
in response to receptor- or store-operated signals including ER calcium store depletion 72. More
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specifically, TRPC6 can be directly activated by diacylglycerol (DAG) produced by receptoractivated phospholipase C (PLC) without any involvement of store-operated mechanisms

73

.

Store-operated calcium entry (SOCE) can be triggered by any process that empties the
intracellular stores of calcium (i.e. endoplasmic reticulum), regardless of the mechanism by
which store depletion is accomplished 74, 75. Despite the established role of TRCP6 as a receptoroperated channel, in pulmonary artery smooth cells, TRPC6 is upregulated in response to chronic
hypoxia enhancing SOCE

76

. Accordingly, ER store depletion with thapsigargin induced

translocation of TRPC6 channels to the plasma membrane

77

. Interestingly, functional TRPC6

assembles into homo- and heterotetaramers including other members of the TRPC3/6/7

78

,

suggesting that supra-molecular complexes with other adaptor proteins may be present. For
example, in PC12 cells a TRPC6 multiprotein complex is present containing protein kinase C
(PKC), FK-506-binding protein-12kDa (FKBP12) and calcineurin /calmodulin

79

. The

physiological role of TRPC6 is largely unknown but growing evidence suggests its involvement
in various pathological conditions. Six mutations in TRPC6 gene are linked to the human kidney
disease focal and segmental glomerulosclerosis (FSGS) 80, 81. Three of these mutation result in a
gain of function and therefore enhance TRPC6 signaling resulting in a pathogenic calcium
overload leading to dysregulation and cell death

81

. Altered expression and function of TRPC6

channels has also been involved in the development of hypoxic
artery hypertension, angiotensin-induced cardiac hypertrophy
85

, and Alzheimer’s disease

86

84

82

and idiopathic

83

pulmonary

, Duchenne muscular dystrophy

. Despite the dispute about the modes of TRPC6 activation, the

signaling events leading to its transcriptional control are not well understood.
Notch is a type-I transmembrane receptor present at the plasma membrane as a
heterodimer (Fig. 12). Notch heterodimerization occurs in the trans-Golgi by a furin-like
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convertase, during the secretion process 87-89. Notch consists of an ectodomain known as NECD
(Notch extracellular domain) linked non-covalently to the Notch transmembrane region (NTM)
90

. At the cell surface, Notch can interact with one of its ligands expressed in a neighboring cell

and get activated

91

. In mammals, there are four Notch genes and five genes encoding ligands,

three Delta-like and two Jagged

92, 93

. This interaction renders NTM sensitive to cleavage by

extracellular metalloproteases of the ADAM/TACE (a desintegrin and metallopeptidase/tumor
necrosis α converting enzyme) family

94-96

. Subsequently, the remaining membrane Notch

fragment undergoes proteolytic cleavage by a γ-secretase protein complex releasing NICD 97-100.
NICD translocates to the nucleus where it acts as a co-activator inducing transcriptional
activation of its target genes 99, 101.

Fiuza, UM. et al, 2007

Figure 12. Notch signaling activation
Notch signaling affects cell fate decisions by critically influencing cell proliferation,
differentiation, and apoptosis

102

. In Drosophila, lack of functional Notch showed an increase

number of neuroblasts at the expense of epidermal precursors
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103

. The functions of Notch,

however, are not restricted to neurogenesis but also involved in the development of other tissues
like vessels, thymus, somite, central nervous system, heart, kidney and hematopoietic cells 104-113.
These functions of Notch are accomplished by tight regulation of its signaling activity that solely
depends on the generation of NICD and/or its nuclear concentration 98. However, the mechanism
and conditions by which NICD is generated are of great importance and uncover connections
between Notch trafficking and signaling activity

114

. As previously discussed, Numb is a

membrane associated protein that inhibits Notch signaling. Numb is acting upstream of the γsecretase by physically interacting with Notch and α-adaptin, a component of the AP2 clathrinadaptor complex 115, suggesting that Numb may affect the endocytic fate of Notch. Alternatively,
Numb interacts with the E3 ubiquitin ligase AIP4/Itch to promote ubiquitination, endocytosis
and degradation of Notch1

58

. We have shown that Numb affects the endocytic trafficking and

proteolytic fate of APP in an isoform specific manner (Kyriazis GA, et al. 2008). More
specifically, the SPTB-Numb induced the accumulation of APP in the early endosomal and
recycling compartments accompanied by enhanced proteolytic processing and generation of Aβ.
Due to the striking processing similarity between Notch and APP it is conceivable that Numb
may also affect Notch endocytic fate in an isoform specific manner therefore affecting the
generation of NICD.
Here we show that SPTB-Numb increase the expression of TRPC6 calcium channels and
enhance SOCE compared to LPTB-Numb. SPTB-Numb mediate these transcriptional effects on
TRPC6 by a mechanism that enhances Notch signaling. Furthermore, neural cells subjected to
serum deprivation also enhance Notch activity inducing TRPC6 upregulation, effects that are
preceded by a selective upregulation of the SPTB Numb isoform in expense of the LPTB one. In
contrast, LPTB-Numb subjected to serum deprivation failed to increase Notch signaling or
42

TRPC6 expression, conferring protection from cell death. Taken together, these results suggest
an isoform specific role of Numb in modulating calcium homeostasis by a mechanism that
involves Notch-mediated transcriptional regulation of TRPC6 calcium channels.
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Materials and methods
Antibodies and reagents
The polyclonal antibodies to the following protein were obtained: Rab5a (Santa Cruz),
actin (Sigma), Notch1-M20 and Notch1-G20 (Santa Cruz), TRPC6 (Chemicon), TRPC-3,-6
(gifts from Dr. Schilling). Immunofluorescence-conjugated secondary antibodies (Alexa Fluor
488-conjugated goat anti-mouse and Alexa Fluor 594-conjugated rabbit anti-goat IgG) were
obtained from Molecular Probes. Additional reagents included: Lipofectamine Plus reagent
(Invitrogen), DAPT (Calbiochem), β-secretase inhibitor IV (Calbiochem), Thapsigargin (LC
Laboratories).

Cell culture and treatments
PC12 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 10%
fetal bovine serum (FBS) (Invitrogen) and maintained at 370C in a 5% CO2 95% air atmosphere.
PC12 cells stably expressing Numb variants have been described previously

27

. Serum

deprivation was accomplished by washing the cells with phosphate-buffered saline (PBS) and
then maintained them in serum-free Locke’s buffer

26

for designated times. DAPT (40μM) and

β-secretase inhibitor IV (10μM) in Opti-MEM I was used to inhibit γ-secretase and β-secretase
activity respectively. Thapsigargin (1mM) in Locke’s Ca2+-free was used to inhibit SERCA.
Jagged-1 peptide (15μM) in DMEM 1% FBS was used to activate Notch1 or appropriate
scramble control (15μM) after washing cells 5 times with DMEM 1% FBS with 5 min
incubations at 370C in a 5% CO2 95% air atmosphere between washes.
44

Intracellular calcium measurements
Cells were cultured on poly-L-lysine-coated glass-bottomed chambers for 24-hr prior to
intracellular Ca2+ experiments in DMEM + 10% FBS medium. Chambers were mounted onto the
stage of an Olympus IX-50 fluorescent microscope equipped with an Hg excitation lamp and a
Myocyte Photometry System (IonOptix, Milton, MA). Cells were superfused with DMEM
saturated with 95% O2-5% CO2 at 37° and containing 1.8 mmol/L Ca2+. A 90% confluent area of
20-30 cells was chosen for each experiment. Cells were loaded with Indo-1 by incubation in
Tyrode’s solution containing (in mmol/L): 138 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1
MgCl2, 10 Hepes, 10 Glucose and 10 μmol/L Indo-1 AM ester (Molecular Probes, Eugene, OR),
pH=7.4, at room temperature for 35 min. After loading, oxygenated DMEM superfusate at 37°
was returned for 10 min to wash-out unincorporated dye. Experimental protocols were
performed in Locke’s solution with Ca2+ (2.0mM), or in Ca2+-free Locke’s solution with EGTA
(100μM) saturated with 95% O2-5% CO2 at 37°. The 405nm and 475nm emission of Indo-1
excited at 340nm was collected by a double-photometer unit, and Ca2+ ratio transients were
recorded in Ion Wizard v4.44 (IonOptix). Fluorescence quench was recorded at 360 nm using
MnCl2 (Mn2+ 200μmol/L). At the conclusion of all experiments, background numerator and
denominator counts were measured from a cell-free region of the coverslip.
For the experimental procedure cells were equilibrated in Ca2+-free Locke’s for 9 min (in
15 sec intervals) and then thapsigargin (1mM) was added. Measurements were taken for 15min
and until Ca2+ ratio readings plateau. Cells were then superfused with Ca2+ Locke’s solution.
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Measurements continued for 6min after Ca2+ peak was recorded. Ratiometric units were
converted to intracellular Ca2+ concentrations by the Grynkiewicz equation 116:
[Ca2+] = K d β (R – R min)/(R max – R)
Ionomycin Ca2+ salt (Sigma) (2 µmol/L in DMEM) was applied before background
measurements at the conclusion of experiments to obtain R

max

value. These values were pooled

for each set of experiments of particular cell type and culture protocol. Ionomycin at higher
concentrations was observed to cause morphological changes and loss of cell adherence,
implying lethality. No significant change in R

max

was observed from 1-5 µmol/L. R

min

value

was the mean of background-subtracted ratios obtained from an experimental chamber without
cells containing Ca2+-free Locke’s and 10 µM Indo-1 Na+ salt.

Cell death assays
Cells were plated on cover slips in 24-wells. Cells were washed with PBS and then
treated with serum withdrawal medium for designated times. Then cells were washed twice with
PBS and incubated for 15 minutes at 37°C with 2μm propidium iodide (PI) and 5μg/ml of
Hoechst dye in PBS. Cells were washed twice with PBS and fixed with 4% paraformaldehyde
for 1 hour at room temperature. Cover slips were mounted at microscope slides using DPX
mountant for histology (Fluka) and visualized under a fluorescent microscope (Carl Zeiss). Cells
were counted and the percent cell death was assessed using a ratio of PI stained cells to total
Number of cells (Hoechst staining) in the field.
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siRNA
Stably transfected PC12 cells with Numb SPTB-Numb were cultured as described above
to 50% confluency. TRPC6 were knock downed using Stealth siRNA (Invitrogen) (TRPC6:
AACAUUCCAAAGUCAAGCAUAUUCC), each with its complementary sequence or Stealth
RNAi Negative control duplex (Invitrogen). Cells plated and transfected with 200nM of siRNA
and Lipophectamine 2000 (Invitrogen) in Opti-MEM I reduced medium without serum for 24-48
hours and then subjected to the experimental treatments described above.

RNA isolation and Real-Time PCR
Total RNA from cells grown in 60mm dishes was isolated using Trisol reagent
(Invitrogen). RNA (2μg) was used to synthesize cDNA using Enhanced Avian HS RT-PCR Kit
(SIGMA). Real time quantitative PCR was performed using an iCycler (BioRad). Amplification
was performed in a final volume of 20 µl, including cDNA from the reverse transcribed reaction,
primer mixture (0.4 µM each of sense and antisense primers), and 12.5 µl 2x SYBR Green Master
Mix (BioRad). The oligonucleotide primers are listed on Table 1. A serially diluted positive
control sample was used to create a standard curve and determine the sensitivity and linearity of
the assay. The standard amplification program included 40 cycles of two steps, each comprising
heating to 95 °C and heating to 60 °C. Fluorescent product was detected at the last step of each
cycle. In order to verify the purity of the products, a melting curve was produced after each run.
To determine the relative quantization of gene expression, the comparative threshold cycle
method ( CT) was used 117. Variation in RNA quantity and quality was controlled using GAPDH
or 18S ribosome RNA as internal controls. To calculate a relative Ct for the target molecules
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(TRPC channels) of interest the CT of the control gene was subtracted from the CT of the gene of
interest to yield the

CT. The final mRNA levels were normalized according to their Ct values

from the standard curves.

Table 1. Oligonucleotide sequences of primers used for Real Time RT-PCR
Target Gene

Accession
Number

TRPC1

AF061266

TRPC2

NM017011

TRPC3

AB022331

TRPC4

NM_080396

TRPC5

AY064411

TRPC6

NM_053559

TRPC7

XM_225159

18S

X01117

GAPDH

NM_017008

Numb

NM_133287

Numb-LPTB

NM_133287

Notch1

NM_001105721

HES-1

NM_024360

Orientation
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

Sequence (5'-3')
CGACACCTTCCACTCGTTCA
GCGCTAAGGAGAAGATGTACCAGA
GTTCCAGTTTCTCTTCTGGACCAT
CAGCATCGTCCTCGATCTTCT
CATGCAGTGCAAAGACTTCGTAG
TTCAGAATGGCTTCCACCTCTT
CTCTGCAGATATCTCTGGGAAGAAT
CACGAGGCAGTATATGAATAAGAACTTT
TGAAACCCTTCAGTCACTCTTCTG
AGTAGCTCCCACAAACTCCGTG
AGTGTACAGAATGCAGCCAGAAAC
CAGCCCTTTGTAGGCATTGATC
CCCTTTAACCTGGTGCCGA
TGGAGTTCAGCATGCCCATT
GTAACCCGTTGAACCCCATT
CCATCCAATCGGTAGTAGCG
ACCCCTTCATTGACCTCAACT
ATGCCAGTGAGCTTCCCGTCAGC
TCAAGAGGAATGCACATCTGTGAAG
TTCATCCACAACTCTGAGTCCATC
GGAAGTTCTTCAAAGGCTTCTTTG
TTCATCCACAACTCTGAGTCCATC
TGGAGCTACCTGCACTGACTATC
TCTCCTCGGAGCAGTTAGACC
AAAGATAGCTCCCGGCATTC
CCTCACACGTGGACAGGAA
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Results
SPTB-Numb is characterized by SOCE and increased expression of TRPC
calcium channels
We have previously shown that SPTB-Numb demonstrated significantly higher [Ca2+]i
relative to vector (VT) and LPTB-Numb after treatment with bradykinin
induces calcium release from the ER

118

27

, an agonist that

. In order to elucidate whether the bradykinin-evoked

transient [Ca2+]i increase in SPTB-Numb is due to an enhanced ER calcium pool, VT, SPTBNumb, and LPTB-Numb were treated with thapsigargin in calcium-free medium. Thapsigargin
depletes the ER calcium pool by irreversibly inhibiting the sarcoplasmic/endoplasmic Ca2+ATPase pump (SERCA)

119

.

SPTB-Numb showed increased calcium concentration after

thapsigargin treatment compared to VT and LPTB-Numb, indicating that SPTB-Numb have
enlarged ER calcium pool (Fig 13.a). Depletion of the endogenous calcium pool induces SOCE,
via a mechanism that involves specific channels 120. Following depletion of the ER calcium pool
with TG, calcium (2 mM) was added to the medium to induce SOCE. SPTB-Numb demonstrated
an enhanced SOCE compared to VT and LPTB-Numb (Fig 13.a). TRPC channels are the most
likely candidates in mediating SOCE

121

, so we measured the expression levels of TRPC

channels in neural cells stably expressing the Numb isoforms . VT express TRPC1 and moderate
levels of TRCP3 under basal conditions. TRPC2, -4, -5, and -7 are either minimally expressed or
undetected (Fig 13.b). Similar findings were observed in the LPTB-Numb. In contrast, in SPTBNumb the expression levels of most TRPC channels were increased. Interestingly, the expression
levels of TRPC3 and TRPC6 channels were 36-fold and 95-fold higher respectively in SPTBNumb compared to VT (Fig 13.b).
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Figure 13. Thapsigargin-induced SOCE and TRPC calcium channel expression.
(a) Composite traces of [Ca2+]i as a function of time are shown. Cells were perfused with
Locke’s Ca2+-free medium with 100μM EGTA for 6 minutes. Thapsigargin (1mM) was added
and [Ca2+]i was recorded for 8 minutes. Cells were then perfused with Locke’s Ca2+ (2 mM) and
SOCE was recorded. (b) Relative expression levels of TRPC channels in the stable PC12 clones
normalized to 18s mRNA (n=6; *p<0.01 vs. VT and LPTB-Numb). Data are mean ± SEM.
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Serum deprivation-induced cell death is mediated by TRPC6 upregulation
We have previously shown that SPTB-Numb exhibited increased susceptibility to cell
death upon serum deprivation

27

. Since SPTB-Numb were found to have high expression levels

of TRPC3 and TRPC6 we tested whether the increased vulnerability of these clones is mediated
by these channels. PC12 cells were subjected to serum deprivation for various time points (8, 16,
and 24 hours) and the expression levels of TRPC3 and TRPC6 were measured. Cell death was
significantly increased after 24h of serum deprivation compared to untreated control
(40.8±0.46% vs. 3.6±0.70%) (Fig 14.a). TRPC6 mRNA was increased at 16h (16.51±4.96-fold)
and 24h (27.32±6.46-fold) of serum deprivation compared to untreated control (Fig 14.b; left
panel). These mRNA changes in TRPC6 were accompanied by increases in the protein levels
(4.97±0.38-fold) (center panel), as well as by accumulation of TRPC6 at the cell membrane
(right panel). No significant upregulation of TRPC3 mRNA was observed (Fig 14.c).
Interestingly, the serum deprivation-induced upregulation of TRPC6 in PC12 cells was preceded
(at 8h) by a significant upregulation (1.59±0.07-fold) of the SPTB spliced isoform of Numb (Fig
14.d). This finding is consistent with the upregulation of TRPC6 observed in SPTB-Numb. In
order to further elucidate the significance of the SPTB isoform of Numb in the regulation of
TRPC6 channel, we tested whether similar changes can be observed in the LPTB-Numb, where
the LPTB isoform of Numb is overexpressed. No significant upregulation of mRNA or protein
levels of either TRPC6 or TPRC3 was observed (Fig 14.e), suggesting that the presence of the
SPTB-Numb isoform may be necessary for such changes to occur. Then we tested whether the
absence of TRPC6 upregulation in LPTB-Numb confers protection against serum deprivation.
Indeed, cells death was significantly lower in LPTB-Numb (6.34±0.005%) compared to VT
(20.43±0.048%) after 16h of serum deprivation (Fig 14.f). Moreover, to further confirm the role
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of TRPC6 upregulation in serum deprivation-induced cell death, we used siRNA to knock down
TRPC6 and test whether it will decrease the vulnerability of PC12 cells. Treatment with siRNA
(siTRPC6) successfully reduced the mRNA levels of TRPC6 (0.53±0.15-fold) compared to
scramble control, after 24h of serum deprivation (Fig 14.g). Cell death was significantly reduced
in PC12 cells treated with siTRPC6 (37.71±4.56%) compared to scramble (67.15±5.24%) after
24h of serum deprivation (Fig 14.h). These results suggest that, at least in PC12 cells, TPRC6
upregulation is implicated in the serum deprivation-induced cell death, and that the SPTB
isoform of Numb may mediate its upregulation.
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Figure 14. TRPC6 upregulation mediates serum deprivation-induced cell death in PC12
cells via a mechanism that involves the SPTB isoform of Numb
(a) Percent (%) cell death in VT after 24h of serum deprivation (n=3; *p<0.0001). (b)
Fold change in TRPC6 mRNA (left panel; n=6) and protein levels (center panel; n=3), and
TRPC6 cellular localization (right panel) in VT after 24h of serum deprivation compared to
untreated control (*p<0.01). (c) Fold change in TRCP3 mRNA levels in VT after serum
deprivation compared to untreated controls (n=6). (d) Fold change in the SPTB isoform of Numb
mRNA levels in VT after serum deprivation compared to untreated controls (n=6; *p=0.003). (e)
Fold change in TRPC3 and TRPC6 mRNA and protein levels in LPTB-Numb after serum
deprivation compared to untreated controls (n=6). (f) Percent (%) cell death in VT and LPTBNumb before and after serum deprivation (n=3; *p<0.0001). (g) Fold change in TRPC6 mRNA
levels in VT treated with scramble or siRNA directed to TRPC6 (siTRPC6) after 24h of serum
deprivation (n=3; *p=0.015). (h) Percent (%) cell death in VT treated with scramble or siTRPC6
before and after 24h of serum deprivation (n=3; *p=0.013). Data are mean ± SEM.
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Notch signaling is enhanced in SPTB-Numb
Numb is involved in asymmetric cell division during embryogenesis by antagonizing
Notch signaling

56, 122

. It has been suggested that the effects of Numb in regulating Notch-

mediated signaling may be isoform-specific

123

. As such, we tested whether Notch signaling is

differentially affected by overexpressing Numb isoforms. Notch is activated by cleavage and
release of its intracellular domain (NICD), which then translocates to the nucleus regulating the
transcriptional activity of target genes

101, 124

. Protein levels of NICD were increased in SPTB-

Numb (0.98±0.02) compared to VT (0.77±0.009) and LPTB-Numb (0.61±0.01) (Fig 15.a).
NICD was largely localized into the nucleus of SPTB-Numb suggesting increased transcriptional
activity (Fig 15.b). A well reported downstream transcriptional target gene of NICD is
Hairy/Enhancer of Split-1 (HES-1) 103. In order to test whether the accumulation of NICD in the
nucleus of SPTB-Numb clones is accompanied by increased transcriptional activity the relative
levels of HES-1 mRNA were assessed. We found increased levels of HES-1 expression in
SPTB-Numb (321.2±39.40) compared to VT (49.00±9.31) and LPTB-Numb (42.02±2.90) (Fig
15.c), confirming that Notch signaling in SPTB-Numb is enhanced. Then, we tested whether the
increased activity of Notch in SPTB-Numb is due to altered expression of Notch1 gene, or
enhanced γ-secretase activity. Neither Notch1 expression (Fig 15.d), nor the activities of γsecretase (Fig 15.e) were different in SPTB-Numb compared to VT and LPTB-Numb.
Considering that Numb promotes ubiquitination, endocytosis and degradation of Notch1
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we

speculated that Numb isoforms may differentially affect the endocytic fate of Notch. In SPTBNumb, Notch1 co-localized with Rab5a, a marker of early endosome formation (Fig 15.f; left
column). No such co-localization between Notch1 and Rab5a was observed in LPTB-Numb (Fig
55

15.f; right column). These data suggest that SPTB-Numb may alter Notch activity by promoting
its accumulation in distinct endocytic compartments.
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Figure 15. Notch signaling is enhanced in SPTB-Numb
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LPTB

(a) Protein levels of the active form of Notch (NICD) in vector (VT), SPTB-Numb and
LPTB-Numb respectively (n=3; *p<0.001). (b) Cellular localization of Notch-NICD (green) in
VT, SPTB-Numb and LPTB-Numb with Hoechst nuclear staining (blue). Merge of Notch and
Hoechst nuclear staining (bottom panel). (c) HES-1 and (d) Notch1 mRNA expression in VT,
SPTB-Numb and LPTB-Numb respectively (n=3; *p<0.001). (e) Relative γ-secretase activities
in VT, SPTB-Numb and LPTB-Numb respectively. (f) Cellular localization of Rab5 (red) and
Notch (green) with Hoechst nuclear staining (blue). Merge of Rab5, Notch, and Hoechst nuclear
staining (bottom panel). Data are mean ± SEM.

Serum deprivation increases Notch signaling in PC12 cells
Since Notch signaling is enhanced in cell overexpressing SPTB-Numb and TRPC6
upregulation mediates the serum deprivation-induced cell death in PC12 cells, we tested whether
serum deprivation would also activate Notch signaling in PC12 cells. We subjected all clones to
serum deprivation for various time points and measured the protein levels of NICD. NICD
protein was significantly increased in VT clones after 16 h (3.86±0.51-fold) and peaked at 24 h
(5.23±0.32-fold) of serum deprivation (Fig 16.a; center panel). These changes in NICD protein
induced a significant mRNA upregulation of HES-1 (4.61±1.17-fold) after 16 h of serum
deprivation (Fig 16.a; right panel). No significant NICD protein upregulation was observed in
SPTB-Numb or LPTB-Numb upon serum deprivation (Fig 16.a; left panel). It has been
suggested that Notch1 signaling is required to sustain Notch1 gene transcription via a positive
feedback loop 125. Consequently, we tested whether the NICD protein upregulation in VT is due
to enhanced transcriptional regulation of Notch1, or increased proteolytic cleavage of Notch by
γ-secretases. The mRNA level of Notch1 was increased at 16 h (1.86±0.14-fold) and peaked at
24 h (3.38±0.67-fold) of serum deprivation, partly explaining the protein upregulation of NICD
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(Fig 16.b). In contrast, no significant increases in Notch1 mRNA were detected in LPTB-Numb
consistent with the absence of NICD changes (Fig 16.c). Moreover, serum deprivation induced a
time-dependent cellular redistribution of NICD to the nucleus of VT (Fig 16.d), supporting the
aforementioned increases in NICD protein and Notch transcriptional activity. Collectively, these
data suggest that the TRPC6 upregulation in SPTB-Numb and in response to serum deprivation
may be mediated by a mechanism that involves increased Notch activity.
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Figure 16. Serum deprivation increases Notch signaling in PC12 cells
Cells were subjected to serum deprivation or untreated control for various times. (a)
Western blot of NICD levels with actin as loading control in VT, SPTB-Numb and LPTB-Numb
(left panel). Fold change of NICD protein in VT (n=3; *p<0.005) (center panel). Fold change of
HES-1 mRNA in VT (n=3; *p<0.007) (right panel) (b-c) Fold change of Notch1 mRNA in VT
and LPTB-Numb (n=3; *p=0.001, **p=0.031). (d) Time course of NICD expression and nuclear
redistribution (green) in VT with nuclear staining (blue). Merge of α-Notch and Hoechst nuclear
staining (bottom panel). Data are mean ± SEM.

Suppression of Notch signaling by a γ-secretase inhibitor attenuates TRPC6
expression in SPTB-Numb
NICD is released upon proteolytic cleavage by a protein complex that contains γsecretase activity

97, 98

. As such, we tested whether a know γ-secretase inhibitor, N-[N-(3,5-

difluorophenacetyl-L-alanyl)]-(S)-phenylglycine t-butyl ester (DAPT), can attenuate the
increased expression of TRPC6 in SPTB-Numb. DAPT (40μM) treatment for 24 h was adequate
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to decrease the relative expression of HES-1 mRNA (321.2±39.4 vs. 247.8±35.1) in SPTBNumb consistent with reduced proteolytic release of NICD and attenuated transcriptional activity
of its downstream target genes (Fig 17.a). Interestingly, TRPC6 mRNA expression was also
reduced (241.5±29.9 vs. 102.5±34.6) in SPTB-Numb, but no effects were observed in the mRNA
expression of TRPC3 (Fig 17.b). These transcriptional changes were also accompanied by
reduced TRPC6 protein levels (0.51±0.01-fold) in SPTB-Numb compared to untreated control
(Fig 17.c; right panel). No changes at the protein levels of TRPC3 were observed (Fig 17.c; left
panel). These data demonstrate that γ-secretase inhibition selectively attenuates the
transcriptional upregulation of TRPC6 in SPTB-Numb, suggesting an involvement of Notch
signaling. Several substrates other than Notch are cleaved by γ-secretase, releasing their
intracellular domain which, in most cases, contains biologically relevant properties

126

. APP, a

well characterized substrate of γ-secretase, is cleaved by β- and γ-secretases releasing Aβ at the
extracellular space and the transcriptionally active APP intracellular domain (AICD) in the
cytoplasm 127. We have shown that Numb regulates APP trafficking and processing, so we tested
whether a β-secretase inhibitor could also attenuate TRPC6 upregulation in SPTB-Numb.
Treatment with the β-secretase inhibitor IV (10μM) for 24 h did not effect TRPC3 or TRPC6
expression (Fig 17.d). These results are consistent with the notion that the effects of DAPT on
TRPC6 attenuated expression are mediated by inhibition of Notch signaling and not by APP.
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Figure 17. Notch inhibition abrogates TRPC6 upregulation in SPTB-Numb
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Vector (VT) and SPTB-Numb were treated with DAPT (40μM), or β-secretase inhibitor
IV (10μM) for 24h. (a) HES-1 mRNA expression levels in VT and SPTB-Numb before and after
DAPT treatment (n=6; *p=0.007). (b) TRPC6 and TRPC3 mRNA expression levels in VT and
SPTB-Numb before and after DAPT treatment (n=6; *p=0.01). (c) Western blot of TRPC3 and
TRPC6 protein levels in VT and SPTB-Numb before and after DAPT treatment (left panel). Fold
change of TRPC6 protein in SPTB-Numb before and after DAPT treatment (right panel) (n=3;
*p=0.037). (d) TRPC6 and TRPC3 mRNA expression levels in VT and SPTB-Numb before and
after β-secretase inhibitor treatment (n=3). Data are mean ± SEM.

Jagged1- mediated activation of Notch induces TRPC6 upregulation in PC12
cells
Since inhibition of Notch signaling attenuated TPRC6 expression in SPTB-Numb we set
to investigate whether activation of Notch signaling can confer the opposite effects and
upregulate the transcription of TRPC6 in PC12. In mammals, Jagged-1 is a well characterized
Notch ligand, which upon binding to Notch receptors induces the release of NICD and therefore
Notch signaling activation 128. PC12 cells were treated with either rat Jagged-1 peptide (15μM),
or a scramble control peptide (15μM) for various time points and the mRNA expression levels of
HES-1, TRCP3, TRPC6 and SPTB isoform of Numb were measured. Jagged-1 peptide activated
Notch signaling by inducing HES-1 mRNA expression after 4 h of treatment (1.85±0.10-fold)
compared to scramble control peptide (Fig 18.a). Similarly, Jagged-1 peptide treatment induced
TRPC6 mRNA at 4 h (11.83±4.11-fold) compared to scramble control peptide (Fig 18.b). No
effects on TRPC3 mRNA expression were detected (Fig 18.c). These results suggest that Notch
selectively upregulates the expression of TRPC6 in PC12 cells. Activation of Notch signaling did

62

not affect the expression of SPTB isoform of Numb (Fig 18.d), suggesting that the Notchmediated transcriptional regulation of TRCP6 can occur independently of Numb functions.
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Figure 18. Notch activation induces the expression of TRPC6 in PC12 cells
PC12 cells (VT) were treated with Jagged-1 peptide (15μM), or scramble control peptide
(SC) (15μM) for designated times and the expression of various genes was assessed. Fold
changes in mRNA of (a) HES-1 (n=4; *p<0.001), (b) TRPC6 (n=4; *p=0.015), (c) TRPC3
(n=4), and (d) SPTB isoform of Numb (n=4) after Jagged-1 treatment compared to scramble
control (VT SC). Data are mean ± SEM.

Increased levels of TRPC6 channels account for the enhanced SOCE in SPTBNumb
We have shown that TRCP6 is upregulated in SPTB-Numb and that DAPT treatment
attenuates its expression via a mechanism that involves Notch signaling. It is conceivable that the
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increased levels of TRPC6 calcium channels may partly explain the increased ER calcium pool
and enhanced SOCE in SPTB-Numb. Therefore, we tested whether DAPT treatment can reduce
[Ca2+]i in response to thapsigargin treatment by attenuating TRPC6 expression. Changes in
[Ca2+]i were assessed in vector and SPTB-Numb after treatment with thapsigargin calcium-free
solution. The calcium response to thapsigargin treatment was reduced in SPTB-Numb pre-treated
with DAPT for 24 h compared to untreated control (Fig 19.a; left panel). These differences in
[Ca2+]i after thapsigargin-induced depletion of calcium pool were manifested by a reduced
calcium peak (374.6±30.42 vs. 205.9±44.96) (Fig 19.a; center panel), as well as by an overall
attenuated calcium response to thapsigargin, assessed by calculating the area under the curve for
each treatment (3.87±0.33 vs. 2.5±0.06) (Fig 19.a; right panel). VT pre-treated with DAPT did
not induce any changes in [Ca2+]i under similar conditions (Fig 19.b). Additionally, we tested
whether DAPT treatment would also affect SOCE in VT and SPTB-Numb. Cells were treated
with thapsigargin in calcium-free solution until steady state was reached. Calcium (2mM) was
added in the medium and [Ca2+]i was recorded. Pre-treatment with DAPT for 24 h significantly
decreased SOCE in SPTB-Numb (Fig 19.c), but not in VT (Fig 19.d). In order to exclude the
possibility that these changes are mediated by an upregulation of proteins that are know to
facilitate ER calcium uptake and sequestration, we assessed the protein levels of SERCA and
Grp78/94 respectively. There were no differences in the protein levels of SERCA and Grp78/94
(Fig 19.e). Finally, in order to demonstrate the direct role of TRPC6 in enhancing SOCE in
SPTB-Numb, we used siRNA to knock down TRPC6. The mRNA and protein levels of TRPC6
were significantly reduced (0.38±0.12-fold and 0.47±0.02-fold respectively) compared to
scramble (SC) control peptide (Fig 19.f). We set to confirm that the changes in [Ca2+]i upon
DAPT pre-treatment and thapsigargin-induced calcium depletion specifically reflect calcium
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influx via TRPC6 channels. We measured the effects of extracellular MnCl2 (Mn2+ 200μM) on
the rate at which Fura-2 fluorescence at 360nm (F360) was quenched. Mn2+ enters the cell as a
Ca2+ surrogate and reduces F360 upon binding to the dye. The rate of quenched F360 was assessed
in the presence of thapsigargin (ER Ca2+ store depletion) to measure Ca2+ influx in SPTB-Numb
treated with either siTRPC6 or scramble control peptide. Quenching of F360 by Mn2+ was lower
in siTRPC6 treated SPTB-Numb (shown on the trace are higher F/F0), suggesting that Ca2+
influx was significantly lower when TRPC6 was knocked down (Fig 19.g). Collectively, these
results demonstrate that the TRPC6 upregulation may in part account for the enhanced SOCE
that characterize the SPTB-Numb.
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Figure 19. TRPC6 upregulation mediates the enhanced SOCE in SPTB-Numb
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(a) SPTB-Numb were pre-treated with DAPT (40μM) in OptiMEM or OptiMEM alone
for 24h. Cells were then perfused with Locke’s Ca2+-free medium with 100μM EGTA for 6
minutes. Thapsigargin (1mM) was added, as indicated, and fluorescent ratio changes from
baseline (Δ F340/F380) were recorded, in 30 second intervals, until steady state was reached (left
panel). Ca2+ peak was assessed as the largest change of [Ca2+]i from baseline (n=4; *p=0.36)
(center panel). The area under the curve was calculated as the sum of individual trapezoid areas
(n=4; *p<0.01) (right panel). (b) Same as described in (a) using VT (n=4). (c) SPTB-Numb were
pretreated with DAPT (40μM) in OPTIMEM or OPTIMEM alone for 24h. Cells were then
perfused with Locke’s Ca2+-free medium with 100μM EGTA for 6 minutes and thapsigargin
(1mM) was then added for 20 minutes. Cells were then perfused with Locke’s including Ca2+
(2mM), as indicated, and SOCE was recorded as fluorescent ratio changes from baseline (Δ
F340/F380), in 30 second intervals (n=4; *p<0.02) (left panel). (d) Same as described in (c) using
VT (n=4). (e) Western blots showing protein levels of SERCA, Grp94/Grp78 and actin as
loading control among VT, SPTB-Numb and LPTB-Numb. (f) Fold change of TRCP6 mRNA
(n=6; *p=0.01, left panel) and protein (n=3; *p=0.004, center panel) levels of SPTB-Numb
treated with TRPC6 siRNA (siTRPC6), or scramble (SC) control. Fluorescent intensity and
localization of TRCP6 in SPTB-Numb treated with siTRPC6 compared to VT or scramble
control (right panel). (g) Comparison of Mn2+ quenching of Fura-2 fluorescence in SPTB-Numb
treated with siTRPC6 or scramble control. Traces illustrate the time course and magnitude of
Mn2+ quenching. The fluorescence as a function of time (F) was normalized to the fluorescent
value measured immediately before the addition of Mn2+ (F0) (n=3; *p<0.05 vs. scramble). Data
are mean ± SEM.
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Discussion
Mammalian Numb produce four isoforms that differ in the length of their PTB and/or
PRR domains

59, 65

. In neural progenitor cells, Numb isoforms containing the long PRR domain

promote proliferation, while those cells lacking the insert promote cell differentiation 65. In NGFinduced differentiated PC12, Numb isoform lacking the insert at the PTB domain enhances
neurite outgrowth compared to the isoforms containing the insert

27

. As such, it is conceivable

that Numb may regulate diverge cell functions in an isoform specific way. We have previously
shown that Numb modifies neural cell calcium homeostasis in an isoform-specific manner, and
thereby may regulate cell survival

26

. More specifically, SPTB-Numb demonstrated increased

calcium responses to bradykinin and enhanced [Ca2+]i after serum deprivation. These data
suggest that Numb may mediate mechanisms that affect the ER calcium pool, thus regulating
calcium-dependent processes.
Here we show that Numb affects SOCE in an isoform-specific manner via a mechanism
that induces transcriptional upregulation of TRPC calcium channels. TRPC belong to the
superfamily of TRP calcium channels that are activated in response to receptor stimulation and
activation of different isoforms of protein lipase C (PLC), or activation by diacylglycerol (DAG)
73, 129, 130

. Despite the unequivocal role of TRPC in receptor-mediated calcium entry, their

involvement in SOCE has not been well characterized 131, 132. In neuroblasts, serum deprivation
induces ER store depletion, a process that activates SOCE mechanisms 133. Therefore, we tested
whether the TRPC calcium channels are involved the serum deprivation-induced susceptibility to
cell death in neural cells. Serum deprivation selectively upregulated TRPC6 channels in PC12
cells, consistent with a recent report where chronic hypoxia in pulmonary arterial smooth muscle
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cells increased TRPC6 leading to enhanced Ca2+ entry through SOCE mechanisms

76

. We also

found that TRPC6 accumulated at the plasma membrane of PC12 consistent with reports
showing that SOC channels transported in cytoplasmic vesicles fuse with the plasma membrane
to mediate SOCE 134, 135. Furthermore, siRNA against TRPC6 significantly protected PC12 cells
from serum deprivation confirming the selective role of TRCP6 in mediating serum deprivationinduced cell death by altering calcium homeostasis. Accordingly, siTRPC6 reduced calcium
influx in SPTB-Numb after calcium store depletion demonstrating that high levels of TRCP6 can
mediate SOCE mechanisms. Consistent with our findings, TRPC6 channels translocated to the
plasma membrane in response to store depletion by thapsigargin, indicating a store-dependent
involvement of TRPC6 channels

136

. TRCP6 can be directly activated by receptor-operated

signaling resulting in activated PLC or increased DAG, without the involvement of internal
calcium stores

73

. Our results however, suggest that TRPC6 is involved in SOCE, induced by

depletion of ER calcium pool. TRPC6 and TRPC3 are largely non-selective cation channels,
suggesting that the inward current passing through them can be attributed to Na+ ions

137, 138

.

Along these lines, stimulation of Ca2+ entry via TRPC6 channels in A7r5 smooth muscle cells
was abolished by voltage-gated calcium channel blockers, suggesting that Na+ entry through
TRPC6 and the subsequent membrane depolarization induced much of Ca2+ influx

139

. The

expression levels of TRPC6 and TRPC3 in SPTB-Numb was approximately 100-fold and 36fold higher respectively compared to VT. Moreover, the SPTB-Numb display phenotypic
characteristic similar to differentiated PC12 cells

27

, which express high levels of L-type Ca2+

channels 140. Conceivably, it is possible that the involvement of TRPC6 in SOCE is mediated by
secondary effects on membrane depolarization and activation of L-type Ca2+ channels.
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During embryogenesis, Numb antagonizes the functions of Notch; however, Numb is
expressed in many adult mammalian cells suggesting additional functions that may also be
mediated by Notch. The biochemical mechanism by which Numb antagonizes Notch is not clear
56, 122, 141, 142

. It has been suggested that Numb interacts with NICD preventing its nuclear

localization and therefore transcriptional activity

143

. More specifically, Numb induces

ubiquitination of Notch1 by recruiting the E3 ligase Itch, a process that requires the PTB domain
of Numb

58

. These data suggest that the Numb isoforms that differ in the PTB domain may

differentially regulate Notch activity. Indeed, we found increased levels of NICD in SPTBNumb compared to VT and LPTB-Numb. NICD was primarily localized to nucleus of SPTBNumb resulting in increased expression of HES-1, a known transcriptional target to Notch
signaling. Therefore, it is possible that Notch may mediate the transcriptional upregulation of
TRCP6 in SPTB-Numb. We used DAPT, a known γ-secretase inhibitor, to reduce the release of
NICD, thereby attenuating Notch activity. Consistent with our hypothesis, DAPT reduced the
expression of TPRC6 in SPTB-Numb. Furthermore, activation of Notch by jagged-1 peptide, a
known Notch ligand, induced increases in TRPC6 expression in VT, confirming that Notch
mediates the transcriptional upregulation of TRPC6 in SPTB-Numb. DAPT treatment in SPTBNumb also reduced ER calcium pool and attenuated [Ca2+]i in response to store depletion
consistent with the changes in TRPC6 expression.
Notch signaling plays an important role in cell differentiation, proliferation and apoptosis
144

, therefore we tested whether serum deprivation would enhance Notch activity in neural cells

illuminating its role on TRPC6 transcriptional regulation. Serum deprivation increased the levels
of NICD in neural cells and induced its nuclear translocation in a time-dependent manner
consistent with the observed increases in the TRPC6 levels. Our results are in accordance with
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previous findings where NICD levels were significantly elevated after cerebral ischemia in mice,
while intravenous infusion of DAPT reduced NICD levels and ameliorated ischemia-induced
brain damage 145.
Interestingly, the changes in Notch activity and the concomitant upregulation in TRPC6
were preceded by a significant switch in Numb isoform expression favoring the upregulation of
the SPTB over the LPTB Numb isoform. This early upregulation of SPTB Numb isoform after
serum deprivation supports the notion that Numb may modulate Notch activity in an isoform
specific manner. Interestingly, LPTB-Numb suppressed serum deprivation-induced activation of
Notch and the subsequent upregulation of TRPC6 and conferred protection against cell death.
The latter finding further strengthens the link between the Numb isoform specific effect on
Notch activation and the Notch-dependent upregulation of TRPC6. Numb colocalized with
endocytic vesicles and was shown to directly bind to Notch as well as the ear domain of αadaptin

115

. These findings dictate a role of Numb as an adaptor between α-adaptin and Notch

promoting the down-regulation of Notch by endocytosis. We have shown that the PTB Numb
isoforms differentially affect the sorting of APP to the recycling and degradative pathways
(Kyriazis GA, et al., 2008). Accordingly, in SPTB-Numb Notch was found to accumulate in the
early endosome where it was shown to colocalize with Rab5a, an early endosomal marker. It has
been suggested that endocytosis is important in NICD release and signaling. For instance,
inhibition of the late endosome can activate Notch signaling by redirecting its trafficking via the
early endosomal compartments

146

. Therefore, accumulation of Notch in early endocytic

compartments may lead to its activation suggesting that γ-secretase activity occurs in places
other than the cell surface

147

. It is possible that the SPTB Numb isoform induces ectopic
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activation of Notch by directing its sorting in compartments where γ-secretase-mediated
proteolytic processing is present.
In summary, we showed that Numb can modulate calcium homeostasis in an isoformspecific manner by increasing the transcription of TRCP6 calcium channels. These effects of
Numb are mediated by an isoform-specific regulation of Notch activity. Moreover, serum
deprivation induces Notch activation and TRPC6 upregulation resulting in calcium dysregulation
and cell death (Fig 20). The consequences of Notch-mediated TRPC6 regulation in disease
models are not known yet. Notch signaling is activated upon ischemic stroke suggesting a
contribution of Notch to neuronal cell death 145. It is plausible that during stress Notch mediates
its detrimental effects by specifically targeting TRPC6 and calcium homeostasis. Although, this
is the first report showing that TRCP6 is a transcriptional target of Notch signaling, the precise
transcriptional mechanism remains known. Finally, understanding the factors that regulate the
alternative splicing of Numb proteins may serve as a molecular target to control the functions of
Notch and its downstream signals.
NOTCH

Ca2+

SERUM
DEPRIVATION

SOCE


α
γ



NICD

?

?

SPTB-NUMB
ISOFORM

Rab5

γ





α

STORE DEPLETION

NICD
EARLY ENDOSOME

CELL DEATH
TRANSCRIPTIONAL
REGULATION

TRPC6
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In pro-neuronal PC12 cells, serum deprivation selectivity upregulates the SPTB isoform
of numb, favoring the shorting of Notch at early endosomal compartments, inducing an increase
in NICD generation and Notch transcriptional activity. In turn, Notch mediates the
transcriptional upregulation of TRPC6 calcium channels, which regulate calcium homeostasis
via a store-operated calcium entry (SOCE) mechanism. The notch-mediated TRPC6 upregulation
and its subsequent effects on calcium flux partly account for the serum deprivation- induced cell
death in PC12 cells.
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